However, the later-stage knockdown of Drp1 may worsen non-alcoholic steatohepatitis (NASH) due to excessive lipotoxicity and a heightened mitochondrial stress response. Here, DNM1L is linked to metabolic dysfunction-associated steatohepatitis.